Clopidogrel versus Other Antiplatelet Agents for Secondary Prevention of Vascular Events in Adults with Acute Coronary Syndrome or Peripheral Vascular Disease: Clinical and Cost-Effectiveness Analyses.
about
Clopidogrel versus Other Antiplatelet Agents for Secondary Prevention of Vascular Events in Adults with Acute Coronary Syndrome or Peripheral Vascular Disease: Clinical and Cost-Effectiveness Analyses.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Clopidogrel versus Other Antip ...... d Cost-Effectiveness Analyses.
@ast
Clopidogrel versus Other Antip ...... d Cost-Effectiveness Analyses.
@en
type
label
Clopidogrel versus Other Antip ...... d Cost-Effectiveness Analyses.
@ast
Clopidogrel versus Other Antip ...... d Cost-Effectiveness Analyses.
@en
prefLabel
Clopidogrel versus Other Antip ...... d Cost-Effectiveness Analyses.
@ast
Clopidogrel versus Other Antip ...... d Cost-Effectiveness Analyses.
@en
P2093
P2860
P1476
Clopidogrel versus Other Antip ...... d Cost-Effectiveness Analyses.
@en
P2093
S Banerjee
P2860
P577
2012-03-01T00:00:00Z